From Jan. 1, 2026, a health insurer will not be able to fund organ transplant surgery if the operation takes place in China or the organ is from China.
Article 7 of the regulations allows the regime to openly seize foreign businesses’ intellectual property, said former Chinese rights lawyer Wu Shaoping.